Your browser doesn't support javascript.
loading
The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.
Brown, Katrina F; Rumgay, Harriet; Dunlop, Casey; Ryan, Margaret; Quartly, Frances; Cox, Alison; Deas, Andrew; Elliss-Brookes, Lucy; Gavin, Anna; Hounsome, Luke; Huws, Dyfed; Ormiston-Smith, Nick; Shelton, Jon; White, Ceri; Parkin, D Max.
Afiliação
  • Brown KF; Policy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK. katrina.brown@cancer.org.uk.
  • Rumgay H; Policy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
  • Dunlop C; Policy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
  • Ryan M; Policy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
  • Quartly F; Policy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
  • Cox A; Policy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
  • Deas A; NHS National Services Scotland, Information Services Division, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, Scotland.
  • Elliss-Brookes L; National Cancer Registration and Analysis Service, Public Health England, 2nd Floor, Skipton House, 80 London Road, London, SE1 6LH, UK.
  • Gavin A; Northern Ireland Cancer Registry, Centre for Public Health, Queens University Belfast, Mulhouse Building, Grosvenor Road, Belfast, BT12 6DP, Ireland.
  • Hounsome L; National Cancer Registration and Analysis Service, Public Health England, 2nd Floor, Skipton House, 80 London Road, London, SE1 6LH, UK.
  • Huws D; Welsh Cancer Intelligence and Surveillance Unit, Floor 5, Public Health Wales, Number 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ, Wales.
  • Ormiston-Smith N; Policy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
  • Shelton J; Policy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
  • White C; Welsh Cancer Intelligence and Surveillance Unit, Floor 5, Public Health Wales, Number 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ, Wales.
  • Parkin DM; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Br J Cancer ; 118(8): 1130-1141, 2018 04.
Article em En | MEDLINE | ID: mdl-29567982
ABSTRACT

BACKGROUND:

Changing population-level exposure to modifiable risk factors is a key driver of changing cancer incidence. Understanding these changes is therefore vital when prioritising risk-reduction policies, in order to have the biggest impact on reducing cancer incidence. UK figures on the number of risk factor-attributable cancers are updated here to reflect changing behaviour as assessed in representative national surveys, and new epidemiological evidence. Figures are also presented by UK constituent country because prevalence of risk factor exposure varies between them.

METHODS:

Population attributable fractions (PAFs) were calculated for combinations of risk factor and cancer type with sufficient/convincing evidence of a causal association. Relative risks (RRs) were drawn from meta-analyses of cohort studies where possible. Prevalence of exposure to risk factors was obtained from nationally representative population surveys. Cancer incidence data for 2015 were sourced from national data releases and, where needed, personal communications. PAF calculations were stratified by age, sex and risk factor exposure level and then combined to create summary PAFs by cancer type, sex and country.

RESULTS:

Nearly four in ten (37.7%) cancer cases in 2015 in the UK were attributable to known risk factors. The proportion was around two percentage points higher in UK males (38.6%) than in UK females (36.8%). Comparing UK countries, the attributable proportion was highest in Scotland (41.5% for persons) and lowest in England (37.3% for persons). Tobacco smoking contributed by far the largest proportion of attributable cancer cases, followed by overweight/obesity, accounting for 15.1% and 6.3%, respectively, of all cases in the UK in 2015. For 10 cancer types, including two of the five most common cancer types in the UK (lung cancer and melanoma skin cancer), more than 70% of UK cancer cases were attributable to known risk factors.

CONCLUSION:

Tobacco and overweight/obesity remain the top contributors of attributable cancer cases. Tobacco smoking has the highest PAF because it greatly increases cancer risk and has a large number of cancer types associated with it. Overweight/obesity has the second-highest PAF because it affects a high proportion of the UK population and is also linked with many cancer types. Public health policy may seek to mitigate the level of harm associated with exposure or reduce exposure levels-both approaches may effectively impact cancer incidence. Differences in PAFs between countries and sexes are primarily due to varying prevalence of exposure to risk factors and varying proportions of specific cancer types. This variation in turn is affected by socio-demographic differences which drive differences in exposure to theoretically avoidable 'lifestyle' factors. PAFs at UK country level have not been available previously and they should be used by policymakers in devolved nations. PAFs are estimates based on the best available data, limitations in those data would generally bias toward underestimation of PAFs. Regular collection of risk factor exposure prevalence data which corresponds with epidemiological evidence is vital for analyses like this and should remain a priority for the UK Government and devolved Administrations.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article